1 . Nestle FO, Kaplan DH, Barker J. "Psoriasis" . New England Journal of Medicine. 2009; 361(5):496–509.

2 . Yost J, Gudjonsson JE. "The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities" . F1000 Med Rep. 2009May8; 1:30. doi: DOI: 10.3410/M1-30. PMID: 20948750; PMCID: PMC2924720.

3 . Chima M, Lebwohl M. "TNF inhibitors for psoriasis" . Semin Cutan Med Surg. 2018Sep; 37(3):134–142. doi: DOI: 10.12788/j.sder.2018.039. PMID: 30215629.

4 . Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler DA, Finlay AY, Griffiths CE, Jackson K, McHugh NJ, McKenna KE, Reynolds NJ, Ormerod AD; (Chair of Guideline Group). "British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009" . Br J Dermatol. 2009Nov; 161(5):987–1019. doi: DOI: 10.1111/j.1365-2133.2009.09505.x. PMID: 19857207.

5 . Emer JJ, Frankel A, Zeichner JA. "A practical approach to monitoring patients on biological agents for the treatment of psoriasis" . J Clin Aesthet Dermatol. 2010Aug; 3(8):20–6. PMID: 20877538; PMCID: PMC2945861.

6 . Hanley T, Handford M, Lavery D, Yiu ZZ. "Assessment and monitoring of biologic drug adverse events in patients with psoriasis" . Psoriasis (Auckl). 2016Apr1; 6:41–54. doi: DOI: 10.2147/PTT.S68869. PMID: 29387593; PMCID: PMC5683127.

7 . Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, et al.. "S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update" . J Dtsch Dermatol Ges. 2012Mar; 10Suppl 2:S1–95. doi: DOI: 10.1111/j.1610-0387.2012.07919.x. PMID: 22386073.

8 . Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, et al.. "European S3-guidelines on the systemic treatment of psoriasis vulgaris" . J Eur Acad Dermatol Venereol. 2009Oct; 23Suppl 2:1–70. doi: DOI: 10.1111/j.1468-3083.2009.03389.x. Erratum in: J Eur Acad Dermatol Venereol. 2010 Jan;24(1):117-8. PMID: 19712190.

9 . Richter L, Vujic I, Sesti A, Monshi B, Sanlorenzo M, Posch C, et al.. "Etanercept, adalimumab, and ustekinumab in psoriasis: analysis of 209 treatment series in Austria" . J Dtsch Dermatol Ges. 2017Mar; 15(3):309–317. doi: DOI: 10.1111/ddg.13191. Epub 2017 Feb 27. PMID: 28240404.

10 . Jabbar-Lopez ZK, Yiu ZZN, Ward V, Exton LS, Mohd Mustapa MF, Samarasekera E, Burden AD, Murphy R, Owen CM, Parslew R, Venning V, Warren RB, Smith CH. "Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis" . J Invest Dermatol. 2017Aug; 137(8):1646–1654. doi: DOI: 10.1016/j.jid.2017.04.009. Epub 2017 Apr 27. Erratum in: J Invest Dermatol. 2021 Feb;141(2):463. PMID: 28457908; PMCID: PMC5519491.

11 . Huang W, Cordoro KM, Taylor SL, Feldman SR. "To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis" . J Am Acad Dermatol. 2008Jun; 58(6):970–7. doi: DOI: 10.1016/j.jaad.2008.03.004. Epub 2008 Apr 2. PMID: 18384909.

12 . van Lümig PP, Driessen RJ, Roelofs-Thijssen MA, Boezeman JB, van de Kerkhof PC, de Jong EM. "Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab" . Br J Dermatol. 2011Aug; 165(2):375–82. doi: DOI: 10.1111/j.1365-2133.2011.10329.x. PMID: 21428975.

13 . Hamadah IR, Al Raddadi AA, Bahamdan KA, Fatani MI, Alnahdi A, Al Rakban AM, et al.. "Saudi practical guidelines on biologic treatment of psoriasis" . J Dermatolog Treat. 2015Jun; 26(3):223–9. doi: DOI: 10.3109/09546634.2014.946882. Epub 2014 Aug 7. PMID: 25075955.

14 . Al Jahdali HH, Baharoon S, Abba AA, Memish ZA, Alrajhi AA, AlBarrak A, et al.. "Saudi guidelines for testing and treatment of latent tuberculosis infection" . Ann Saudi Med. 2010Jan-Feb; 30(1):38–49. doi: DOI: 10.4103/0256-4947.59373. PMID: 20103957; PMCID: PMC2850181.

15 . Sivamani RK, Goodarzi H, Garcia MS, Raychaudhuri SP, Wehrli LN, Ono Y, et al.. "Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring" . Clin Rev Allergy Immunol. 2013Apr; 44(2):121–40. doi: DOI: 10.1007/s12016-012-8301-7. PMID: 22311162.

16 . Abu Shaikha S, Mansour K, Riad H. "Reactivation of Tuberculosis in Three Cases of Psoriasis after Initiation of Anti-TNF Therapy" . Case Rep Dermatol. 2012Jan; 4(1):41–6. doi: DOI: 10.1159/000337145. Epub 2012 Feb 25. PMID: 22529801; PMCID: PMC3331879.

17 . Schmitt J, Zhang Z, Wozel G, Meurer M, Kirch W. "Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials" . Br J Dermatol. 2008Sep; 159(3):513–26. doi: DOI: 10.1111/j.1365-2133.2008.08732.x. Epub 2008 Jul 9. PMID: 18627372.

18 . Torii H, Nakagawa H; "Japanese Infliximab Study investigators. Infliximab mono-therapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial" . J Dermatol Sci. 2010Jul; 59(1):40–9. doi: DOI: 10.1016/j.jdermsci.2010.04.014. Epub 2010 May 4. PMID: 20547039.

19 . Menter A, Feldman SR, Weinstein GD, Papp K, Evans R, Guzzo C, et al.. "A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis" . J Am Acad Dermatol. 2007Jan; 56(1):31.e1–15. doi: DOI: 10.1016/j.jaad.2006.07.017. Epub 2006 Sep 6. PMID: 17097378.

20 . Kimball AB, Schenfeld J, Accortt NA, Anthony MS, Rothman KJ, Pariser D. "Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States" . Br J Dermatol. 2015Nov; 173(5):1183–90. doi: DOI: 10.1111/bjd.14068. Epub 2015 Oct 11. PMID: 26265015.

21 . Rungapiromnan W, Yiu ZZN, Warren RB, Griffiths CEM, Ashcroft DM. "Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials" . Br J Dermatol. 2017Apr; 176(4):890–901. doi: DOI: 10.1111/bjd.14964. Epub 2017 Mar 14. PMID: 27518205; PMCID: PMC5412670.